Analyst Marc Goodman works at LEERINK and is focused on the Healthcare sector with 481 price targets and ratings documented since 2010 spanning on 34 stocks. Previously, Marc Goodman worked at UBS. Analyst's average stock valuation to be materialised ratio is 58.8% with an average time for price targets to be met of 243.97 days.
Most recent stock forecast was given on MRNS, at 23-Jan-2023.
Marc Goodman best performing recommendations are on SAGE (SAGE THERAPEUTICS, INC).
The best stock recommendation documented was for SAGE (SAGE THERAPEUTICS, INC) at 12/4/2019. The price target of $63 was fulfilled within 1 day with a profit of $86.21 (57.78%) receiving and performance score of 577.78.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Buy
157
$12.16 (8.40%)
155
20 days ago
33/34 (97.06%)
$24.49 (29.07%)
425
Buy
182
$37.16 (25.66%)
178
2 months ago
14/22 (63.64%)
$25.08 (28.76%)
561
Hold
140
$-4.84 (-3.34%)
172
2 months 29 days ago
0/2 (0%)
$25.87 (23.60%)
Hold
155
$10.16 (7.01%)
160
3 months 6 days ago
7/8 (87.5%)
$12.27 (10.71%)
76
Buy
169
$24.16 (16.68%)
174
3 months 6 days ago
11/13 (84.62%)
$16.17 (14.62%)
118
